SEC Form 4 · accession 0000913165-18-000030

EXACTECH INC · EXAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President, R&D

Period of report

Feb 14, 2018

Accepted (ET)

Feb 16, 2018 · 4:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000913165

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 14, 2018	S$0	47,650	$0.00	D	94,720	I	by Partnership
Common Stock	Feb 14, 2018	S	94,720	$49.25	D	0	I	by Partnership
Common Stock	Feb 14, 2018	S	13,189	$49.25	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Incentive Stock Option (right to buy)^F3	$16.33	Feb 14, 2018	S	19,800	D	Feb 22, 2017	Feb 22, 2019	Common Stock	19,800	D
Incentive/Non-Qualified Option (right to buy)^F3	$18.55	Feb 14, 2018	S	16,000	D	Feb 25, 2018	Feb 25, 2020	Common Stock	16,000	D
Non-Qualified Stock Option (right to buy)^F3	$20.90	Feb 14, 2018	S	12,000	D	May 9, 2019	May 9, 2021	Common Stock	12,000	D
Non-Qualified Stock Option (right to buy)^F3	$23.28	Feb 14, 2018	S	9,000	D	Apr 29, 2020	Apr 29, 2022	Common Stock	9,000	D
Non-Qualified Stock Option (right to buy)^F3	$30.55	Feb 14, 2018	S	9,000	D	May 3, 2022	May 3, 2024	Common Stock	9,000	D

F1Shares were disposed of pursuant to an Agreement and Plan of Merger, dated October 22, 2017, as amended by Amendment No.1 dated as of December 3, 2017, by and among Osteon Holdings, L.P. ("Parent"), Osteon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent , and Exactech, Inc., in exchange for equity interests in Parent, each with value equal to or less than $49.25, on the effective date of the merger.
F2Shares were disposed of pursuant to an Agreement and Plan of Merger, dated October 22, 2017, as amended by Amendment No.1 dated as of December 3, 2017, by and among Osteon Holdings, L.P., Osteon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent , and Exactech, Inc., in exchange for $49.25 per share on the effective date of the merger.
F3Pursuant to the Agreement and Plan of Merger, dated October 22, 2017, as amended by Amendment No.1 dated as of December 3, 2017, by and among Osteon Holdings, L.P., Osteon Merger Sub, Inc., an indirect wholly owned subsidiary of Parent, and Exactech, Inc., the option was canceled in exchange for a cash payment equal to $49.25 per share underlying such option minus the per share exercise price of the option, less any required withholding of taxes.